A self-management app to improve asthma control in adults with limited health literacy: a mixed-method feasibility study.
Asthma
Feasibility study
Health literacy
Low-and-middle-income countries (LMIC)
Mobile application
Self-management
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
27 09 2023
27 09 2023
Historique:
received:
05
10
2022
accepted:
18
09
2023
medline:
4
10
2023
pubmed:
28
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
Digital technology tailored for those with limited health literacy has the potential to reduce health inequalities. Although mobile apps can support self-management in chronic diseases, there is little evidence that this approach applies to people with limited health literacy. We aimed to determine the acceptability of a self-management app in adults living with asthma and have limited health literacy and the feasibility of delivering the intervention and assessing outcomes. We recruited eligible adults from the Klang Asthma Cohort registry in primary care for a 3-month mixed-method study plus a 2-month extended observation. We collected baseline data on socio-demography, health literacy and asthma control level. The outcomes of the intervention were assessed at 1- and 3-month: i) adoption (app download and usage), ii) adherence (app usage), iii) retention (app usage in the observation period), iv) health outcomes (e.g., severe asthma attacks) and v) process outcomes (e.g., ownership and use of action plans). At 1-month, participants were purposively sampled for in-depth interviews, which were audio-recorded, transcribed verbatim, and analysed deductively. We recruited 48 participants; 35 participants (23 Female; median age = 43 years; median HLS score = 28) completed the 3 months study. Of these, 14 participants (10 Female; median age = 48 years; median HLS score = 28) provided interviews. Thirty-seven (77%) participants adopted the app (downloaded and used it in the first month of the study). The main factor reported as influencing adoption was the ease of using the app. A total of 950 app usage were captured during the 3-month feasibility study. App usage increased gradually, peaking at month 2 (355 total log-ins) accounting for 78% of users. In month 5, 51.4% of the participants used the app at least once. The main factors influencing continued use included adherence features (e.g., prompts and reminders), familiarity with app function and support from family members. An asthma self-management app intervention was acceptable for adults with limited health literacy and it was feasible to collect the desired outcomes at different time points during the study. A future trial is warranted to estimate the clinical and cost-effectiveness of the intervention and to explore implementation strategies.
Sections du résumé
BACKGROUND
Digital technology tailored for those with limited health literacy has the potential to reduce health inequalities. Although mobile apps can support self-management in chronic diseases, there is little evidence that this approach applies to people with limited health literacy. We aimed to determine the acceptability of a self-management app in adults living with asthma and have limited health literacy and the feasibility of delivering the intervention and assessing outcomes.
METHODS
We recruited eligible adults from the Klang Asthma Cohort registry in primary care for a 3-month mixed-method study plus a 2-month extended observation. We collected baseline data on socio-demography, health literacy and asthma control level. The outcomes of the intervention were assessed at 1- and 3-month: i) adoption (app download and usage), ii) adherence (app usage), iii) retention (app usage in the observation period), iv) health outcomes (e.g., severe asthma attacks) and v) process outcomes (e.g., ownership and use of action plans). At 1-month, participants were purposively sampled for in-depth interviews, which were audio-recorded, transcribed verbatim, and analysed deductively.
RESULTS
We recruited 48 participants; 35 participants (23 Female; median age = 43 years; median HLS score = 28) completed the 3 months study. Of these, 14 participants (10 Female; median age = 48 years; median HLS score = 28) provided interviews. Thirty-seven (77%) participants adopted the app (downloaded and used it in the first month of the study). The main factor reported as influencing adoption was the ease of using the app. A total of 950 app usage were captured during the 3-month feasibility study. App usage increased gradually, peaking at month 2 (355 total log-ins) accounting for 78% of users. In month 5, 51.4% of the participants used the app at least once. The main factors influencing continued use included adherence features (e.g., prompts and reminders), familiarity with app function and support from family members.
CONCLUSIONS
An asthma self-management app intervention was acceptable for adults with limited health literacy and it was feasible to collect the desired outcomes at different time points during the study. A future trial is warranted to estimate the clinical and cost-effectiveness of the intervention and to explore implementation strategies.
Identifiants
pubmed: 37759184
doi: 10.1186/s12911-023-02300-6
pii: 10.1186/s12911-023-02300-6
pmc: PMC10523795
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
194Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
BMC Public Health. 2013 Oct 10;13:948
pubmed: 24112855
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
NPJ Prim Care Respir Med. 2021 Nov 29;31(1):47
pubmed: 34845205
J Health Serv Res Policy. 2008 Apr;13(2):92-8
pubmed: 18416914
Ann Intern Med. 2011 Jul 19;155(2):97-107
pubmed: 21768583
Obes Rev. 2016 Apr;17(4):345-60
pubmed: 26756281
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Int Forum Allergy Rhinol. 2020 Jan;10(1):75-80
pubmed: 31645084
NPJ Prim Care Respir Med. 2021 Jul 7;31(1):38
pubmed: 34234145
Trials. 2014 Jul 03;15:264
pubmed: 24993581
Eur Heart J. 2016 May 07;37(18):1428-38
pubmed: 26873093
Health Informatics J. 2020 Jun;26(2):862-879
pubmed: 31195877
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Respir Med. 2013 Sep;107(9):1346-55
pubmed: 23810267
J Allergy Clin Immunol. 2012 Apr;129(4):935-42
pubmed: 22326486
Heart Lung Circ. 2016 Aug;25(8):802-7
pubmed: 27262389
J Asthma. 2021 Feb;58(2):253-261
pubmed: 31691618
J Glob Health. 2020 Jun;10(1):010427
pubmed: 32566166
Curr Diab Rep. 2016 Jul;16(7):66
pubmed: 27255269
JMIR Mhealth Uhealth. 2016 Jun 09;4(2):e29
pubmed: 27282195
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD000088
pubmed: 17054127
BMC Health Serv Res. 2020 May 27;20(1):475
pubmed: 32460752
J Gen Intern Med. 2013 Mar;28(3):444-52
pubmed: 23065575
J Health Commun. 2011;16 Suppl 3:73-88
pubmed: 21951244
Health Hum Rights. 2020 Dec;22(2):21-32
pubmed: 33390689
J Med Internet Res. 2005 Mar 31;7(1):e11
pubmed: 15829473
Health Expect. 2022 Feb;25(1):163-176
pubmed: 34514689
Patient Educ Couns. 2017 Jun;100(6):1073-1082
pubmed: 28174067
Lancet Respir Med. 2017 Sep;5(9):691-706
pubmed: 28822787
Diabetes Educ. 2014 Jul;40(4):476-487
pubmed: 24737885
J Med Internet Res. 2021 Sep 9;23(9):e26434
pubmed: 34499039
Med J Malaysia. 2011 Mar;66(1):36-41
pubmed: 23765141
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99
pubmed: 19535666
BMC Public Health. 2021 Jun 22;21(1):1186
pubmed: 34158013
J Med Internet Res. 2017 Apr 27;19(4):e136
pubmed: 28450271
J Am Med Inform Assoc. 2017 May 01;24(3):619-632
pubmed: 27694279
Lancet Respir Med. 2020 Aug;8(8):e67-e68
pubmed: 32763207
ERJ Open Res. 2022 Jul 25;8(3):
pubmed: 35891622
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
J Health Serv Res Policy. 2016 Apr;21(2):73-82
pubmed: 26377727